Telemedicine firm begins offering GLP-1 medications to treat addiction

A telemedicine company announced it will now prescribe GLP-1 class drugs to patients with substance-use disorders through its virtual platform.

GLP-1 medications, originally approved for diabetes and weight-loss management, are being explored for their potential to reduce cravings and support recovery, and the company’s move reflects this emerging interest.

The news was highlighted in STAT’s Morning Rounds newsletter, which covers health policy and clinical developments, but the article did not provide further details about the specific drugs, patient eligibility, or pricing.